Literature DB >> 29027011

Let's make microglia great again in neurodegenerative disorders.

Marie-Victoire Guillot-Sestier1,2, Terrence Town3.   

Abstract

All of the common neurodegenerative disorders-Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and prion diseases-are characterized by accumulation of misfolded proteins that trigger activation of microglia; brain-resident mononuclear phagocytes. This chronic form of neuroinflammation is earmarked by increased release of myriad cytokines and chemokines in patient brains and biofluids. Microglial phagocytosis is compromised early in the disease process, obfuscating clearance of abnormal proteins. This review identifies immune pathologies shared by the major neurodegenerative disorders. The overarching concept is that aberrant innate immune pathways can be targeted for return to homeostasis in hopes of coaxing microglia into clearing neurotoxic misfolded proteins.

Entities:  

Keywords:  Innate immunity; Microglia; Neurodegenerative diseases; Neuroinflammation; Phagocytosis; Proteinopathy

Mesh:

Year:  2017        PMID: 29027011      PMCID: PMC5897227          DOI: 10.1007/s00702-017-1792-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  348 in total

1.  Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice.

Authors:  T Wyss-Coray; C Lin; D A Sanan; L Mucke; E Masliah
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra.

Authors:  Toyoko Arimoto; Dong-Young Choi; Xin Lu; Mei Liu; Xuan V Nguyen; Naiying Zheng; Charles A Stewart; Hyoung-Chun Kim; Guoying Bing
Journal:  Neurobiol Aging       Date:  2007-06       Impact factor: 4.673

3.  Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease.

Authors:  Brent Cameron; Wayne Tse; Raza Lamb; Xiaoxia Li; Bruce T Lamb; Gary E Landreth
Journal:  J Neurosci       Date:  2012-10-24       Impact factor: 6.167

4.  Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.

Authors:  Ana Griciuc; Alberto Serrano-Pozo; Antonio R Parrado; Andrea N Lesinski; Caroline N Asselin; Kristina Mullin; Basavaraj Hooli; Se Hoon Choi; Bradley T Hyman; Rudolph E Tanzi
Journal:  Neuron       Date:  2013-04-25       Impact factor: 17.173

5.  Increased plasma TGF-beta1 in patients with amyotrophic lateral sclerosis.

Authors:  K Houi; T Kobayashi; S Kato; S Mochio; K Inoue
Journal:  Acta Neurol Scand       Date:  2002-11       Impact factor: 3.209

6.  Investigation of genes coding for inflammatory components in Parkinson's disease.

Authors:  Anna Håkansson; Lars Westberg; Staffan Nilsson; Silvia Buervenich; Andrea Carmine; Björn Holmberg; Olof Sydow; Lars Olson; Bo Johnels; Elias Eriksson; Hans Nissbrandt
Journal:  Mov Disord       Date:  2005-05       Impact factor: 10.338

Review 7.  TGF-beta 1 is an organizer of responses to neurodegeneration.

Authors:  C E Finch; N J Laping; T E Morgan; N R Nichols; G M Pasinetti
Journal:  J Cell Biochem       Date:  1993-12       Impact factor: 4.429

8.  The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson's disease.

Authors:  Ilona Joniec-Maciejak; Agnieszka Ciesielska; Adriana Wawer; Anna Sznejder-Pachołek; Joanna Schwenkgrub; Agnieszka Cudna; Piotr Hadaczek; Kristof S Bankiewicz; Anna Członkowska; Andrzej Członkowski
Journal:  Pharmacol Rep       Date:  2014-04-08       Impact factor: 3.024

9.  Plaque complement activation and cognitive loss in Alzheimer's disease.

Authors:  David A Loeffler; Dianne M Camp; David A Bennett
Journal:  J Neuroinflammation       Date:  2008-03-11       Impact factor: 8.322

10.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

View more
  6 in total

1.  Megalencephalic Leukoencephalopathy with Subcortical Cysts Protein-1 (MLC1) Counteracts Astrocyte Activation in Response to Inflammatory Signals.

Authors:  Maria Stefania Brignone; Angela Lanciotti; Barbara Serafini; Cinzia Mallozzi; Marco Sbriccoli; Caterina Veroni; Paola Molinari; Xabier Elorza-Vidal; Tamara Corinna Petrucci; Raul Estévez; Elena Ambrosini
Journal:  Mol Neurobiol       Date:  2019-06-17       Impact factor: 5.590

2.  Neuroinflammation in neurodegeneration: role in pathophysiology, therapeutic opportunities and clinical perspectives.

Authors:  Guillaume Dorothée
Journal:  J Neural Transm (Vienna)       Date:  2018-05       Impact factor: 3.575

3.  Plasma MCP-1 and changes on cognitive function in community-dwelling older adults.

Authors:  Juan Luis Sanchez-Sanchez; Kelly V Giudici; Sophie Guyonnet; Julien Delrieu; Yan Li; Randall J Bateman; Angelo Parini; Bruno Vellas; Philipe de Souto Barreto
Journal:  Alzheimers Res Ther       Date:  2022-01-07       Impact factor: 6.982

Review 4.  Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics.

Authors:  Catarina M Abreu; Ricardo Soares-Dos-Reis; Pedro N Melo; João B Relvas; Joana Guimarães; Maria José Sá; Andrea P Cruz; Inês Mendes Pinto
Journal:  Front Mol Neurosci       Date:  2018-05-16       Impact factor: 5.639

5.  Role of Microglia TLRs in Neurodegeneration.

Authors:  Bernd L Fiebich; Carla Ribeiro Alvares Batista; Soraya Wilke Saliba; Nizar M Yousif; Antonio Carlos Pinheiro de Oliveira
Journal:  Front Cell Neurosci       Date:  2018-10-02       Impact factor: 5.505

6.  Microglia Activation in Retinal Ischemia Triggers Cytokine and Toll-Like Receptor Response.

Authors:  Natalie Wagner; Sabrina Reinehr; Marina Palmhof; David Schuschel; Teresa Tsai; Emely Sommer; Viktoria Frank; Gesa Stute; H Burkhard Dick; Stephanie C Joachim
Journal:  J Mol Neurosci       Date:  2020-08-24       Impact factor: 3.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.